BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17313501)

  • 1. Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study.
    Ford AC; Forman D; Bailey AG; Cook MB; Axon AT; Moayyedi P
    Am J Gastroenterol; 2007 May; 102(5):957-65. PubMed ID: 17313501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.
    Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
    Am J Gastroenterol; 2008 May; 103(5):1229-39; quiz 1240. PubMed ID: 18371141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection.
    Wildner-Christensen M; Hansen JM; De Muckadell OB
    Scand J Gastroenterol; 2006 Feb; 41(2):149-54. PubMed ID: 16484119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group.
    Moayyedi P; Forman D; Braunholtz D; Feltbower R; Crocombe W; Liptrott M; Axon A
    Am J Gastroenterol; 2000 Jun; 95(6):1448-55. PubMed ID: 10894577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study.
    Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
    Gut; 2007 Mar; 56(3):321-7. PubMed ID: 16908511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome.
    Su YC; Wang WM; Wang SY; Lu SN; Chen LT; Wu DC; Chen CY; Jan CM; Horowitz M
    Am J Gastroenterol; 2000 Aug; 95(8):1900-5. PubMed ID: 10950033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
    Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study.
    Ford AC; Forman D; Bailey AG; Goodman KJ; Axon AT; Moayyedi P
    Int J Epidemiol; 2007 Dec; 36(6):1327-33. PubMed ID: 17905807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.
    Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
    Am J Gastroenterol; 2012 Jun; 107(6):912-21. PubMed ID: 22472745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study.
    Aro P; Talley NJ; Ronkainen J; Storskrubb T; Vieth M; Johansson SE; Bolling-Sternevald E; Agréus L
    Gastroenterology; 2009 Jul; 137(1):94-100. PubMed ID: 19328797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyspepsia in the community: a follow-up study.
    Jones R; Lydeard S
    Br J Clin Pract; 1992; 46(2):95-7. PubMed ID: 1457318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors associated with dyspepsia in a rural Asian population and its impact on quality of life.
    Mahadeva S; Yadav H; Rampal S; Goh KL
    Am J Gastroenterol; 2010 Apr; 105(4):904-12. PubMed ID: 20179699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.
    Ford AC; Forman D; Nathan J; Crocombe WD; Axon AT; Moayyedi P
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1267-75. PubMed ID: 17944741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study.
    Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
    Aliment Pharmacol Ther; 2008 Oct; 28(8):1013-20. PubMed ID: 18657131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups.
    Talley NJ; Weaver AL; Zinsmeister AR
    Am J Gastroenterol; 1994 Apr; 89(4):524-8. PubMed ID: 8147354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatization an independent psychosocial risk factor for irritable bowel syndrome but not dyspepsia: a population-based study.
    Koloski NA; Boyce PM; Talley NJ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1101-9. PubMed ID: 16957517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing dyspepsia-related consultation: differences between a rural and an urban population.
    Mahadeva S; Yadav H; Everett SM; Goh KL
    Neurogastroenterol Motil; 2011 Sep; 23(9):846-53. PubMed ID: 21740483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.